Effects of Growth Hormone Overexpression and Growth Hormone Resistance on Neuroendocrine and Reproductive Functions in Transgenic and Knock‐Out Mice2

A Bartke, V Chandrashekar, D Turyn… - Proceedings of the …, 1999 - Wiley Online Library
A Bartke, V Chandrashekar, D Turyn, RW Steger, L Debeljuk, TA Winters, JA Mattison…
Proceedings of the Society for Experimental Biology and Medicine, 1999Wiley Online Library
Transgenic mice overexpressing growth hormone (GH) exhibit alterations in the function of
the hypothalamic‐pituitary‐gonadal (HPG) axis and the H‐P‐adrenal axis. Alterations in the
turnover of hypothalamic neurotransmitters, in plasma hormone levels, and in regulation of
their release are associated with reproductive deficits, particularly in females. Results
reported after publication of our minireview on this subject provided evidence that GH‐
transgenic mice have increased binding of GH to GH binding proteins in plasma, are …
Abstract
Transgenic mice overexpressing growth hormone (GH) exhibit alterations in the function of the hypothalamic‐pituitary‐gonadal (HPG) axis and the H‐P‐adrenal axis. Alterations in the turnover of hypothalamic neurotransmitters, in plasma hormone levels, and in regulation of their release are associated with reproductive deficits, particularly in females. Results reported after publication of our minireview on this subject provided evidence that GH‐transgenic mice have increased binding of GH to GH binding proteins in plasma, are hyperinsulinemic and insulin resistant, and have major alterations in energy budgets with increased allocation to growth. Reduced life span and fertility of these animals may be related to insufficient allocation of energy to reproduction and maintenance. Growth hormone resistance induced by transgenic expression of an antagonistic bGH analog or by targeted disruption (knock‐out, KO) of the GH receptor (GH‐R) gene leads to dramatic suppression of plasma levels of insulin‐like growth factor‐1 (IGF‐1), and dwarf phenotype due to reduced growth and increased adiposity. In both models of GH resistance, there are marked reproductive deficits in females, decline of breeding performance of males, and alterations in the function of the HPG axis. In GH‐R‐KO females, puberty is delayed, and litter size is reduced. Fetal weights are reduced whereas placental weights are increased, and the weight of newborn pups is reduced despite an increase in the length of gestation. In GH‐R‐KO males, copulatory behavior and fertility are reduced, plasma PRL is elevated, and responses to lutenizing hormone releasing hormone (LHRH) in vivo and to LH in vitro are suppressed. However, reproductive deficits in GH‐R‐KO mice are very mild when compared to those described previously in IGF‐KO animals. Apparently, the amounts of IGF‐1 that may be produced locally in the absence of GH stimulation are sufficient for sexual maturation and fertility in both sexes, whereas quantitative deficits in reproductive function reflect absence of GH‐dependent IGF‐1 production and other consequences of eliminating GH signaling. The reproduction phenotype of the GH‐R‐KO mice is also mild when compared to dwarf mice that lack GH, prolactin (PRL), and thyroid stimulating hormone (TSH). This is presumably related to the presence of redundant mechanisms in the stimulatory control of the gonads by the pituitary and the ability of animals capable of producing PRL and TSH to compensate partially for the absence of GH signaling.
Wiley Online Library